First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study

被引：0
|
作者：
Djelila Allouache
Sulochana R Gawande
Michele Tubiana-Hulin
Nicole Tubiana-Mathieu
Sophie Piperno-Neumann
Fawzia Mefti
Laurence Bozec
Jean-Yves Genot
机构：
[1] Lion sur mer,Centre F. Baclesse
[2] Lilly Corporate,Eli Lilly and Company
[3] Ctr René Huguenin,undefined
[4] Hopital Dupuytren,undefined
[5] Hospital Curie,undefined
[6] Lilly France,undefined
来源：
BMC Cancer | / 5卷
关键词：
Paclitaxel; Gemcitabine; Metastatic Breast Cancer; Anthracyclines; Inflammatory Breast Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Review of gemcitabine plus taxane combination therapy in the first-line treatment of metastatic breast cancer
    Colomer, Ramon
    EJC SUPPLEMENTS, 2008, 6 (08): : 9 - 12
  • [42] Weekly paclitaxel as first-line chemotherapy for elderly patients with metastatic breast cancer. A multicentre phase II trial
    ten Tije, AJ
    Smorenburg, CH
    Seynaeve, C
    Sparrebooma, A
    Schothorst, KLC
    Kerkhofs, LGM
    van Reisen, LGPM
    Stoter, G
    Bontenbal, M
    Verweij, J
    EUROPEAN JOURNAL OF CANCER, 2004, 40 (03) : 352 - 357
  • [43] A phase II trial of weekly paclitaxel, 5-fluorouracil, and leucovorin as first-line treatment for metastatic breast cancer
    Loesch, DM
    Asmar, L
    Canfield, VA
    Parker, GA
    Hynes, HE
    Ellis, PG
    Ferri, WA
    Robert, NJ
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 77 (02) : 115 - 123
  • [44] Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy
    Gennari, A
    Bruzzi, P
    Orlandini, C
    Salvadori, B
    Donati, S
    Landucci, E
    Guarneri, V
    Rondini, M
    Ricci, S
    Conte, P
    BRITISH JOURNAL OF CANCER, 2004, 90 (05) : 962 - 967
  • [45] Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy
    A Gennari
    P Bruzzi
    C Orlandini
    B Salvadori
    S Donati
    E Landucci
    V Guarneri
    M Rondini
    S Ricci
    P Conte
    British Journal of Cancer, 2004, 90 : 962 - 967
  • [46] A phase II Trial of Weekly Paclitaxel, 5-Fluorouracil, and Leucovorin as First-Line Treatment for Metastatic Breast Cancer
    David M. Loesch
    Lina Asmar
    Vikki A. Canfield
    Gregory A. Parker
    Harry E. Hynes
    Peter G. Ellis
    William A. Ferri
    Nicholas J. Robert
    Breast Cancer Research and Treatment, 2003, 77 : 115 - 123
  • [47] Bevacizumab Combined with Two-weekly Paclitaxel as First-line Therapy for Metastatic Breast Cancer
    Kountourakis, Panteleimon
    Doufexis, Dimitrios
    Maliou, Savoula
    Karagiannis, Athanasios
    Kardara, Eugenia
    Margari, Charalampia
    Sykoutri, Despoina
    Tzovaras, Alexandros
    Ardavanis, Alexandros
    ANTICANCER RESEARCH, 2010, 30 (07) : 2969 - 2971
  • [48] A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinoma
    Perez, EA
    Hillman, DW
    Stella, PJ
    Krook, JE
    Hartmann, LC
    Fitch, TR
    Hatfield, AK
    Mailliard, JA
    Nair, S
    Kardinal, CG
    Ingle, JN
    CANCER, 2000, 88 (01) : 124 - 131
  • [49] Gemcitabine Plus Irinotecan as First-Line Weekly Therapy in Locally Advanced and/or Metastatic Pancreatic Cancer
    Neri, B.
    Cipriani, G.
    Grifoni, R.
    Molinara, E.
    Pantaleo, P.
    Rangan, S.
    Vannini, A.
    Tonelli, P.
    Valeri, A.
    Pantalone, D.
    Taddei, A.
    Bechi, P.
    ONCOLOGY RESEARCH, 2009, 17 (11-12) : 559 - 564
  • [50] The Breast Avastin Trial: phase II study of bevacizumab maintenance therapy after induction chemotherapy with docetaxel and capecitabine for the first-line treatment of patients with locally recurrent or metastatic breast cancer
    G. Bisagni
    A. Musolino
    M. Panebianco
    A. De Matteis
    F. Nuzzo
    A. Ardizzoni
    S. Gori
    T. Gamucci
    R. Passalacqua
    R. Gnoni
    G. Moretti
    C. Boni
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1051 - 1057
12345